Alessia Comes

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Idiopathic Pulmonary Fibrosis

Mechanical Ventilation

Clinical Evaluation

Top Venues

Expert opinion on pharmacotherapy

Expert opinion on drug safety

The European respiratory journal

Expert review of respiratory medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Carmelo Sofia, Alessia Comes, Giacomo Sgalla, Luca Richeldi
Promising advances in treatments for the management of idiopathic pulmonary fibrosis. Expert opinion on pharmacotherapy 25 (6) (2024)
Carmelo Sofia, Alessia Comes, Giacomo Sgalla, Luca Richeldi
Promising advances in treatments for the management of idiopathic pulmonary fibrosis. Expert opinion on pharmacotherapy 25 (6) (2024)
Carmelo Sofia, Alessia Comes, Giacomo Sgalla, Luca Richeldi
Promising advances in treatments for the management of idiopathic pulmonary fibrosis. Expert opinion on pharmacotherapy (2024)
Carmelo Sofia, Alessia Comes, Giacomo Sgalla, Luca Richeldi
An update on emerging drugs for the treatment of idiopathic pulmonary fibrosis: a look towards 2023 and beyond. Expert opinion on emerging drugs (2023)
Alessia Comes, Giacomo Sgalla, Simone Ielo, Tonia Magrì, L Richeldi
Challenges in the diagnosis of idiopathic pulmonary fibrosis: the importance of a multidisciplinary approach. Expert review of respiratory medicine (2023)
Nathan Hambly, Mohammed Abdul Malik Farooqi, Anna Dvorkin-Gheva, Kathryn Donohoe, Kristopher Garlick, Ciaran Scallan, Sy Giin Chong, Sarah MacIsaac, Deborah Assayag, Kerri A Johannson, Charlene D Fell, Veronica Marcoux, Helene Manganas, Julie Morisset, Alessia Comes, Jolene H Fisher, Shane Shapera, Andrea S Gershon, Teresa To, Alyson W Wong, Mohsen Sadatsafavi, Pierce G Wilcox, Andrew J Halayko, Nasreen Khalil, P Gerard Cox, Luca Richeldi, Christopher J Ryerson, Martin R J Kolb
Prevalence and characteristics of progressive fibrosing interstitial lung disease in a prospective registry. The European respiratory journal 60 (4) (2022)
Giacomo Sgalla, Alessia Comes, Marialessia Lerede, Luca Richeldi
COVID-related fibrosis: insights into potential drug targets. Expert opinion on investigational drugs (2021)
Alessia Comes, Giacomo Sgalla, Alessandro Perrotta, Luca Richeldi
Advances with pharmacotherapy for the treatment of interstitial lung disease. Expert opinion on pharmacotherapy 23 (4) (2021)
Giacomo Sgalla, Alessia Comes, Luca Richeldi
An updated safety review of the drug treatments for idiopathic pulmonary fibrosis. Expert opinion on drug safety 20 (9) (2021)